<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Gonçalves Silva, Isabel</dc:creator>
  <dc:creator>Gibbs, Bernhard F.</dc:creator>
  <dc:creator>Bardelli, Marco</dc:creator>
  <dc:creator>Varani, Luca</dc:creator>
  <dc:creator>Sumbayev, Vadim V.</dc:creator>
  <dc:date>2015-09-16</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">The T cell immunoglobulin and mucin domain 3 (Tim-3) is a plasma membrane-associated receptor which is  involved in a variety of biological responses in human immune cells. It is highly expressed in most acute  myeloid leukaemia (AML) cells and therefore may serve as a possible target for AML therapy. However, its  biochemical activities in primary human AML cells remain unclear. We therefore analysed the total  expression and surface presence of the Tim-3 receptor in primary human AML blasts and healthy primary  human leukocytes isolated from human blood. We found that Tim-3 expression was significantly higher in  primary AML cells compared to primary healthy leukocytes. Tim-3 receptor molecules were distributed  largely on the surface of primary AML cells, whereas in healthy leukocytes Tim-3 protein was mainly  expressed intracellularly. In primary human AML blasts, both Tim-3 agonistic antibody and galectin-9 (a Tim- 3 natural ligand) significantly upregulated mTOR pathway activity. This was in line with increased  accumulation of hypoxia-inducible factor 1 alpha (HIF-1α) and secretion of VEGF and TNF-α. Similar results  were obtained in primary human healthy leukocytes. Importantly, in both types of primary cells, Tim-3- mediated effects were compared with those induced by lipopolysaccharide (LPS) and stem cell factor  (SCF). Tim-3 induced comparatively moderate responses in both AML cells and healthy leukocytes.  However, Tim-3, like LPS, mediated the release of both TNF-α and VEGF, while SCF induced mostly VEGF  secretion and did not upregulate TNF-α release.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://n2t.net/ark:/12658/srd1319077</dc:identifier>
  <dc:identifier>https://susi.usi.ch/global/documents/319077</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/319077/files/Goncalves_Silva_O_2015.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.18632/oncotarget.5257</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1319077</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>CC BY</dc:rights>
  <dc:source>Oncotarget. - 2015, vol. 6, no. 32, p. 33823-33833</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Tim-3</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Acute myeloid leukaemia</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Myeloid cells</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns4="xml" ns4:lang="en">Differential expression and biochemical activity of the immune receptor Tim-3 in healthy and malignant human myeloid cells</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
